|
RNF19B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.055800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.94500000000009E-05 |
| Normal-vs-Stage2 |
7.693000E-01 |
| Normal-vs-Stage3 |
2.568600E-01 |
| Normal-vs-Stage4 |
7.906400E-01 |
| Stage1-vs-Stage2 |
4.644400E-02 |
| Stage1-vs-Stage3 |
3.83720000000087E-05 |
| Stage1-vs-Stage4 |
3.739000E-03 |
| Stage2-vs-Stage3 |
2.970600E-01 |
| Stage2-vs-Stage4 |
6.583200E-01 |
| Stage3-vs-Stage4 |
5.317200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.045700E-02 |
| Normal-vs-AfricanAmerican |
7.898600E-01 |
| Normal-vs-Asian |
1.751210E-01 |
| Caucasian-vs-AfricanAmerican |
1.819970E-01 |
| Caucasian-vs-Asian |
1.821770E-01 |
| AfricanAmerican-vs-Asian |
6.100300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.584600E-01 |
| Normal-vs-Female |
2.321000E-03 |
| Male-vs-Female |
7.998800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.706600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.264900E-03 |
| Normal-vs-Age(61-80Yrs) |
4.167000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.380600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.336570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.485000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.405200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.524200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.471000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.976800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.233900E-02 |
| Normal-vs-Grade 2 |
5.445800E-04 |
| Normal-vs-Grade 3 |
3.016000E-01 |
| Normal-vs-Grade 4 |
3.019500E-02 |
| Grade 1-vs-Grade 2 |
2.068400E-01 |
| Grade 1-vs-Grade 3 |
8.180400E-02 |
| Grade 1-vs-Grade 4 |
1.592050E-02 |
| Grade 2-vs-Grade 3 |
2.359600E-02 |
| Grade 2-vs-Grade 4 |
1.77314999999512E-05 |
| Grade 3-vs-Grade 4 |
6.621700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.37590050464098E-10 |
| Normal-vs-ccB subtype |
6.964700E-04 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.096100E-02 |
| Normal-vs-N1 |
5.635200E-01 |
| N0-vs-N1 |
2.833200E-01 |
|
|
